307 related articles for article (PubMed ID: 15696696)
21. New transfusion strategies: red cell substitutes.
Winslow RM
Annu Rev Med; 1999; 50():337-53. PubMed ID: 10073282
[TBL] [Abstract][Full Text] [Related]
22. Physiological capacity of the reticuloendothelial system for the degradation of hemoglobin vesicles (artificial oxygen carriers) after massive intravenous doses by daily repeated infusions for 14 days.
Sakai H; Masada Y; Horinouchi H; Ikeda E; Sou K; Takeoka S; Suematsu M; Takaori M; Kobayashi K; Tsuchida E
J Pharmacol Exp Ther; 2004 Dec; 311(3):874-84. PubMed ID: 15297471
[TBL] [Abstract][Full Text] [Related]
23. [Contributions and prospects of hemoglobin derivatives].
Remy B; Deby-Dupont G; Lamy M
Schweiz Med Wochenschr; 1997 Jun; 127(25):1088-96. PubMed ID: 9312831
[TBL] [Abstract][Full Text] [Related]
24. Performances of PEG-modified hemoglobin-vesicles as artificial oxygen carriers in microcirculation.
Sakai H; Tsuchida E
Clin Hemorheol Microcirc; 2006; 34(1-2):335-40. PubMed ID: 16543654
[TBL] [Abstract][Full Text] [Related]
25. Effects of recombinant-hemoglobin solutions rHb2.0 and rHb1.1 on blood pressure, intestinal blood flow, and gut oxygenation in a rat model of hemorrhagic shock.
Raat NJ; Liu JF; Doyle MP; Burhop KE; Klein J; Ince C
J Lab Clin Med; 2005 Jan; 145(1):21-32. PubMed ID: 15668658
[TBL] [Abstract][Full Text] [Related]
26. [Progress in the red cell substitutes (artificial red cells)].
Tsuchida E
Rinsho Ketsueki; 1994 May; 35(5):439-45. PubMed ID: 8028190
[TBL] [Abstract][Full Text] [Related]
27. Oxygen therapeutics: oxygen delivery without blood.
Stollings JL; Oyen LJ
Pharmacotherapy; 2006 Oct; 26(10):1453-64. PubMed ID: 16999656
[TBL] [Abstract][Full Text] [Related]
28. Current status of injectable oxygen carriers.
Zuck TF; Riess JG
Crit Rev Clin Lab Sci; 1994; 31(4):295-324. PubMed ID: 7888075
[TBL] [Abstract][Full Text] [Related]
29. [Current research on oxygen carriers for transfusion: hemoglobin solutions and fluorocarbon emulsions].
Labrude P
Ann Pharm Fr; 1992; 50(5-6):250-66. PubMed ID: 1307671
[TBL] [Abstract][Full Text] [Related]
30. Polymer/hemoglobin assemblies: biodegradable oxygen carriers for artificial red blood cells.
Li T; Jing X; Huang Y
Macromol Biosci; 2011 Jul; 11(7):865-75. PubMed ID: 21312333
[TBL] [Abstract][Full Text] [Related]
31. Review of hemoglobin-vesicles as artificial oxygen carriers.
Sakai H; Sou K; Horinouchi H; Kobayashi K; Tsuchida E
Artif Organs; 2009 Feb; 33(2):139-45. PubMed ID: 19178458
[TBL] [Abstract][Full Text] [Related]
32. Intraosseous transfusion with liposome-encapsulated hemoglobin improves mouse survival after hypohemoglobinemic shock without scavenging nitric oxide.
Shono S; Kinoshita M; Takase B; Nogami Y; Kaneda S; Ishihara M; Saitoh D; Kikuchi M; Seki S
Shock; 2011 Jan; 35(1):45-52. PubMed ID: 20601932
[TBL] [Abstract][Full Text] [Related]
33. Oxygen therapeutics--current concepts.
Hill SE
Can J Anaesth; 2001 Apr; 48(4 Suppl):S32-40. PubMed ID: 11336435
[TBL] [Abstract][Full Text] [Related]
34. Red blood cell substitutes.
Chang TM
Baillieres Best Pract Res Clin Haematol; 2000 Dec; 13(4):651-67. PubMed ID: 11102282
[TBL] [Abstract][Full Text] [Related]
35. Effects of hemoglobin vesicles, a liposomal artificial oxygen carrier, on hematological responses, complement and anaphylactic reactions in rats.
Abe H; Azuma H; Yamaguchi M; Fujihara M; Ikeda H; Sakai H; Takeoka S; Tsuchida E
Artif Cells Blood Substit Immobil Biotechnol; 2007; 35(2):157-72. PubMed ID: 17453702
[TBL] [Abstract][Full Text] [Related]
36. [Artificial blood in 1990: from a lifelong dream to today's reality].
Vigneron C
Bull Acad Natl Med; 1990 Oct; 174(7):947-57; discussion 957-8. PubMed ID: 2081328
[TBL] [Abstract][Full Text] [Related]
37. Alternative oxygen therapeutics: products, status of clinical trials, and future prospects.
Winslow RM
Curr Hematol Rep; 2003 Nov; 2(6):503-10. PubMed ID: 14561395
[TBL] [Abstract][Full Text] [Related]
38. Repeated injection of high doses of hemoglobin-encapsulated liposomes (hemoglobin vesicles) induces accelerated blood clearance in a hemorrhagic shock rat model.
Taguchi K; Iwao Y; Watanabe H; Kadowaki D; Sakai H; Kobayashi K; Horinouchi H; Maruyama T; Otagiri M
Drug Metab Dispos; 2011 Mar; 39(3):484-9. PubMed ID: 21123166
[TBL] [Abstract][Full Text] [Related]
39. One-year observation of Wistar rats after intravenous infusion of hemoglobin-vesicles (artificial oxygen carriers).
Sakai H; Tsuchida E; Horinouchi H; Kobayashi K
Artif Cells Blood Substit Immobil Biotechnol; 2007; 35(1):81-91. PubMed ID: 17364473
[TBL] [Abstract][Full Text] [Related]
40. Liposome-Encapsulated Hemoglobin, TRM-645: Current Status of the Development and Important Issues for Clinical Application.
Kaneda S; Ishizuka T; Goto H; Kimura T; Inaba K; Kasukawa H
Artif Organs; 2009 Feb; 33(2):146-52. PubMed ID: 19178459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
